Abstract
Hyperthermia has the potential to modify the cytotoxicity of anticancer drugs and to convert some other drugs to cytotoxic agents having no considerable cytotoxicity at normal temperature. This has been demonstrated by in vitro and in vivo experiments, which are compiled in the first part of this review. The pattern of modification of the dose response curves of the drugs and the degree of change of their effectiveness by heat depends on a great variety of factors; not all these are known at present. In this review an attempt is made to compile as many data as possible on these modifying factors. They will be discussed in the context of each specific drug in order to avoid misleading generalizations, but rather to give a “hyperthermic portrayal” of these drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adwankar MK, Chitnis MP (1984) Effect of hyperthermia alone and in combination with anticancer drugs on the viability of P388 leukemic cells. Tumori 70: 231–234
Aigner KR, Walther H, Helling HJ, Link KH (1985) Die isolierte Leberperfusion. Beitr Oncol 21: 43–83, Karger, Basel
Alberts DS, Peng YM, Chen HSG, Moon TE, Cetas TC, Höschele JD (1980) Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. J Natl Cancer Inst 65: 455–461
Anderson RL, Ahier RG, Littleton JM (1983) Observations on the cellular effects of ethanol and hy-perthermia in vivo. Radiat Res 94: 318–325
Andreesen R, Modolell M, Oepke GHF, Munder PG (1983) Temperature dependence of leukemic cell destruction by alkyl-lysophospholipids (NSC 324368). Exp Hemato1 11: 564–570
Ballard BE (1974) Pharmacokinetics and temperature. J Pharmaceut Sci 63: 1345–1358
Barlogie B, Cony PM, Yip E, Lippmann L, Johnston DA, Khalil K, Tenczynski TF, Reilly E, Lawson R, DosikG, Rigor B, Hankenson R, Freireich EJ (1979) Total-body hyperthermia with and without chemotherapy for advanced human neoplasms. Cancer Res 39: 1481–1489
Barlogie B, Cony PM, Drewinko B (1980) In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum (II) and mitomycin C. Cancer Res 40: 1165–1166
Barranco SC, Novak JK, Humphrey RM (1975) Studies on recovery from chemically induced damage in mammalian cells. Cancer Res 35:1194–1204
Bistoni F, Lees DE, Bull J, Bashes AM, Chretien PB, Smith R, Whang-Peng J, Schuette W, De Vita VT (1979) Correlation of serum glycoproteins and blood T-cell levels with clinical course during whole body hyperthermia (WBHT) alone with chemotherapy. Seventieth annual meeting of the American Association for Cancer Research, 16–19 May 1979, New Orleans, Louisiana, Proc Am Assoc Cancer Res 20: 194
Bowden GT, Kasunic M, Sim D (1983) Sequence dependence for the hyperthermic potentiation of cis-diamine diechloroplatinum (II) induced cytotoxicity and DNA damage. Proc. 3rd annual meeting North American Hyperthermia Group (NAHG), 26 Feb-3 March 1983, San Antonio, Texas, pp 161–162
Braun J, Hahn GM (1975) Enhanced cell killing by bleomycin and 43° C hyperthermia and the inhibition of recovery from potentially lethal damage. Cancer Res 35: 2921–2927
Brenner DE, Van Echo D, Riggs CE, Wesley M, Whitacre M, Aisner J, Wienrik PH, Bachur NR (1981) Hyperthermia induced changes in Adriamycin pharmacokinetics in sarcoma patients receiving whole-body hyperthermia (wbh), adriamycin (adr) and cyclophosphamide (ctx). Proceedings 17th annual meeting, American Society of Clinical Oncology, Washington 22: 260
Bronk BY, Wilkins RI, Regan JD (1973) Thermal enhancement of DNA damage by an alkylating agent in human cells. Biochem Biophys Res Commun 52: 1064–1070
Brown DM, Cohen MS, Sayerman RH (1983) Influence of heat on the intracellular uptake and radiosensitization of 2-nitromidazole hypoxic cell sensitizers in vitro. Cancer Res 43: 3138–3142
Bull JM, Lees D, Schütte W, Whang-PengJ, Smith R, Bynum G, Atkinson ER, GottdienerJS, Gralnick HR, ShawkerTH, De Vita VJr (1979) Whole-body hyperthermia: a phase I trial of a potential adjuvant to chemotherapy. Ann Intern Med 90: 317–323
Bull JMC (1984) A review for systemic hyperthermia. In: Veath JM (ed) Hyperthermia and radiation therapy/chemotherapy in the treatment of cancer. Frontiers of radiation therapy and oncology, vol 18. Karger, Basel, pp 171–176
Busch W (1866) Über den Einfluß welche heftige Erysipeln zuweilen auf organisierte Neubildungen ausüben. Verh Naturhist Ges Rhein Westph 23: 28–30
Cavaliere R, Mondovi B, Moricca G, Monticelli G, Natali PG, Santon FS, Di Filippo F, Varanese A, Aloe L, Rossi-Fanelli A (1983) Regional perfusion hyperthermia. In: Storm FK (ed) Hyperthermia in cancer therapy. Hall Medical, Boston, pp 369–399
Chlebowski RT, Block JB, Cundiff D, Dietrich MF (1982) Doxorubicin cytotoxicity enhanced by local anesthetics in a human melanoma cell line. Cancer Treat Rep 66:121–125
Clawson RE, Egorin MJ, Fox BM, Ross LA, Bachur NR (1981) Hyperthermic modification of cyclophosphamide metabolism in rat hepatic microsomes and liver slices. Life Sci 28:1133–1137
Cohen GL, Bauer WR, Barton JK et al (1979) Binding of cis-and trans-dichlorodiammineplatinum (II) to DNA: evidence for unwinding and shortening of the double helix. Science 203: 1014–1016
Cole DR, Pung J, Kim JD, Berman RA, Cole DF (1979) Systemic thermotherapy (whole body hyperthermia). Int J Clin Pharmacol Biopharm 17: 329–333
Coley WB (1893) The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am J Med Sci 105: 487–511
Collins FG, Skibba JL (1979) Effect of hyperthermia and mechlorethamine on hepatic function in isolated perfused liver (meeting abstract). Proc Am Assoc Cancer Res 20: 125
Collins FG, Skibba JL (1983) Altered hepatic functions and microsomal activity in perfused rat liver by hyperthermia combined with alkylating agents. Cancer Biochem Biophys 6: 205–211
Creech Jr O, Krementz ET, Ryan RF, Winblad JN (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148: 616–632
Cronau Jr LH, Bourke DL, Bull JM (1984) General anesthesia for wholebody hyperthermia. Cancer Res (Suppl) 44: 4873s-4877s
Dahl O (1982) Interaction of hyperthermia and Doxorubicin on malignant neurogenic rat cell line in (3T4C) in culture. In: Dethlefsen LA, Dewey WC (eds) 3rd international symposium: cancer therapy by hyperthermia, drugs and radiation, Ft Collins, Colorado 1980. Natl Cancer Inst Monogr 61: 251–253
Dahl O (1983) Hyperthermic potentiation of doxorubicin and 4-epi-doxorubicin in a transplantable neurogenic rat tumor (BT4A) in BD IX rats. Int J Radiat Oncol Biol Phys 9: 203–207
Dahl O, Mella O (1982) Enhanced effect of combined hyperthermia and chemotherapy (Bleomycin, BCNU) in a neurogenic rat tumor (BT4A) in vivo. Anticancer Res 2: 359–364
Dahl O, Mella O (1983) Effect of timing and sequence of hyperthermia and cyclophosphamide on a neurogenic rat tumor (BT4A) in vivo. Cancer 52: 983–987
Dahl O, Mella O (1984) Timing and sequence of hyperthermia and drugs. Hyperthermic oncology 1984, vol 1. Proc 4th int symp on hyperthermic oncology, Aarhus, Denmark, 2–6 July 1984, pp 425–428
Daiy JM, Smith G, Frazier H, Dudrick SJ, Copeland EM (1982) Effects of systemic hyperthermia and intrahepatic infusion with 5-fluorouracil. Cancer 49: 1112–1115
De Martino C, Battelli T, Cavaliere R, Curcio CG, Bellocci M, Manocchi D, Giustini L, Mattioli R, Rinaldi M, Di Filippo F (1984) Morphological damage induced in vivo by Lonidamine on human metastatic cancer cells. Oncology (Supp11) 41: 94–103
De Silva V, Tofilon PJ, Gutin PH, Dewey WC, Buckley N, Deen DF (1985) Comparative study of the effects of hyperthermia and BCNU on BCNU-sensitive and BCNU-resistant 9L rat brain tumor cells. Radiat Res 103: 363–372
Dickson JA, Suzangar M (1974) In vitro-in vivo studies on the susceptibility of the solid Yoshida sarcoma to drugs and hyperthermia (42). Cancer Res 34: 1263–1274
Donaldson SS, Gordon LF, Hahn GM (1978) Protective effect of hyperthermia against the cytotoxicity of actinomycin D on Chinese hamster cells. Cancer Treat Rep 62: 1489–1495
Douglass EC, Bul1 JM, Smith R, Whang-Peng J (1979) Cytogenetic studies in clinical trials of hyperthermia. Seventieth Annual Meeting of the American Association for Cancer Research, May 16–19,1979, New Orleans, Louisiana. Proc Am Assoc Cancer Res 20: 22
Douglas MA, Parks LC, Bebin J (1981) Sudden tnyelopathy secondary to therapeutic total-body hyperthermia after spinal-cord irradiation. N Engl J Med 304: 583–585
Douple EB, Strohbehn JW, de Sieyes DC, Alborough DP, Trembly BS (1982) Therapeutic potentiation of cis-diammineplatinum (II) and radiation by interstitial microwave hyperthermia in a mouse tumor. In: Dethlefsen LA, Dewey WC (eds): 3rd intern symposium: cancer therapy by hyperthermia, drugs and radiation. Natl Cancer Inst Monogr 61: 259–262
Engelhardt R (1985) Whole-body-hyperthermia. Methods and clinical results. Proceedings 4th international symposium hyperthermic oncology, Aarhus, Denmark, 2–6 July 1984, vol 2. Taylor and Francis, London, pp 263–276
Engelhardt R (1986) Clinical requirements of local and regional hyperthermia application. In: Bruggmoser G, Hinkelbein W, Engelhardt R, Wannenmacher M (eds) Locoregional high-frequency hyperthermia and temperature measurement. Springer, Berlin Heidelberg New York Tokyo, pp 1–6 (Recent Results Cancer Res vol 101)
Engelhardt R, Neumann H, von der Tann M, Löhr GW (1982) Preliminary results in the treatment of oat cell carcinoma of the lung by combined application of chemotherapy (CT) and whole-body hyperthermia. In: Gautherie M, Albert E (eds) Biomedical thermology. International symposium, Straßburg 1981. Liss, New York, pp 761–765
Engelhardt R, Neumann H, Hinkelbein W, Adam G, Weth R, Löhr GW (1984) Clinical studies in thermo-chemotherapy. In: Engelhardt R, Wallach DH (eds) Hyperthermia. In: Spitzy KH, Karrer K (eds) Proceedings of the 13th international congress of chemotherapy, Vienna 1983, vol 18. Egermann, Vienna, pp 273/41–273/46
Engelhardt R, Weth-Simon R, Neumann H, Maier-Lenz H (1985) Thermo-Chemotherapie kolo-rektaler Karzinome mit 4’-Epiadriamycin. In: Nagel GA, Wannenmacher M (eds) Farmorubicin: klinische Erfahrungen; gemeinsames Symposium der Arbeitsgemeinschaft für Internisten. Zuckschwerdt, Munich, pp 204–208 (Aktuelle Onkologie, Vol 15)
Fabricius HA, Neumann H, Stahn R, Engelhardt R, Löhr GW (1978) Klinisch-chemische and immunologische Veränderungen bei Gesunden nach einer einstündigen 40° C-Ganzkörperhyperthermie. Klin Wschr 56: 1049–1056
Fairman HD (1982) The treatment of head and neck carcinoma with adriamycin and bleomycin using adjuvant hyperthermia. J Laryngol Otol 96: 251–263
Field SB, Bleehen NM (1979) Hyperthermia in the treatment of cancer. Cancer Treat Rep 6: 63–94
Fisher GA, Hahn GM (1982) Enhancement of cis-diaminedichloroplatinum (cis-DDP) cytotoxicity by hyperthermia. In: Dethlefsen LA, Dewey WC (eds) 3rd international symposium: cancer therapy by hyperthermia, drugs and radiation, Ft Collins, Colorado 1980. Natl Cancer Inst Monogr 61: 255–257
Friedmann CA (1980) Structure-activity relationships of anthraquinones in some pathological conditions. Pharmacology 20: 113–122
Fujiwara K, Kohno I, Miyao J, Sekiba K (1984) The effect of heat on cell proliferation and the uptake of anti-cancer drugs into tumour. Hyperthermic oncology, 1984, vol 1, summary papers. Proceedings of the 4th intern symp on hyperthermic oncology 2–6 July 1984, pp 405–408
Gerad H, Egorin MJ, Whitacre M, Van Echo DA, Aisner J (1983) Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum (II) and whole-body hyperthermia. Cancer Chemother Pharmacol 11: 162–166
Ghussen F, Nagel K, Groth W, Muller JM, Stutzer H (1984) A prospective randomized study of regional extremity perfusion in patients with malignant melanoma. Ann Surg 200: 764–768
Ghussen F, Nagel K, Müller JM, Groth W, Stutzer H (1985) Die regionale Extremitätenperfusion bei Patienten mit malignen Melanomen. Tumor Diagnos Ther 6: 74–78
Goss P, Parsons PG (1977) The effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines. Cancer Res 37: 152–156
Haas GP, Klugo RC, Hetzel FW, Barton EE, Cerny IC (1984) The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma. J Uro1 132: 828–833
Hahn GM (1974) Metabolic aspects of the role of hyperthermia in mammalian cell inactivation and their possible relevance to cancer treatment. Cancer Res 34: 3117–3123
Hahn GM (1978) Interactions of drugs and hyperthermia in vitro and in vivo. In: Streffer C, Van Beuningen D, Dietzel F, Roettinger E, Robinson JE, Scherer E, Seeber S, Trott KR (eds) Cancer therapy by hyperthermia and radiation. Proceedings of the 2nd international symposium, Essen, 2–4 June 1977. Urban and Schwarzenberg, Baltimore, 1978 pp 72–79
Hahn GM (1979) Potential for therapy of drugs and hyperthermia. Cancer Res 39: 2264–2268
Hahn GM (1982) Hyperthermia and cancer. Plenum, New York
Hahn GM (1983) Hyperthermia to enhance drug delivery. In: Chabner BA (ed) Rational basis for chemotherapy UCLA symposia on molecular and cellular biology - New Series, vol 4. UCLA symp on the rational basis for chemotherapy, Keystone, CO, 1982. Liss, New York, pp 427–436
Hahn GM, Strande DP (1976) Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. J Natl Cancer Inst 57: 1063–1067
Hahn GM, Li GC (1982) Interactions of hyperthermia and drugs: treatment and probes. In: Dethlefsen LA, Dewey WC (eds) 3rd international symposium: cancer therapy by hyperthermia, drugs and radiation, Ft Collins, Colorado 1980. Natl Cancer Inst Monogr 61: 317–323
Hahn GM, Shiu EC (1983) Effect of pH and elevated temperature on the cytotoxicity of some Chemotherapeutic agents on Chinese hamster cells in vitro. Cancer Res 43: 5789–5791
Hahn GM, Braun J, Har-Kedar I (1975) Thermochemotherapy: synergism between hyperthermia (42–43°) and adriamycin (or bleomycin) in mammalian cell inactivation (cancer chemotherapy/ cell membranes). Proc Natl Acad Sci USA 72: 937–940
Hahn GM, Li GC, Shue E (1977) Interaction of amphotericin B and 43° C hyperthermia. Cancer Res 37: 761–764
Hall EJ, Astor M, Geard C, Biaglow J (1977) Cytoxicity of Ro-07–0582; enhancement by hyperthermia and protection by cysteamine. Br J Cancer 35: 809–815
Har-Kedar I, Bleehen NM (1976) Experimental and clinical aspects of hyperthermia applied to the treatment of cancer with special reference to the role of ultrasonic and microwave heating. Adv Radiat Biol 6: 229–266
Hassanzadeh M, Chapman IV (1983) Thermal enhancement of bleomycin-induced tumor growth delay: the effect of dose fractionation. Eur J Cancer Clin Onco 119:1517–1519
Hazan G, Ben-Hur E, Yerushalmi A (1981) Synergism between hyperthermia and cyclophosphamide in vivo: the effect of dose fractionation. Eur J Cancer 17: 681–684
Hazan G, Lurie H, Yerushalmi A (1984) Sensitization of combined cis-platinum and cyclophosphamide by local hyperthermia in mice bearing the Lewis lung carcinoma. Oncology 41: 68–69
Heckel M, Heckel I (1979) Beobachtungen an 479 Infrarothyperthermiebehandlungen. Beitrag zur Methodik der Ganzkörperüberwärmung. Med Welt 30: 971–975
Heppner F (1982) New technologies to combat malignant tumors of the brain. Anticancer Res 2: 101–109
Herman TS (1983) Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3- bis (2-chloroethyl)-1-nitrosourea cytotoxity in vitro. Cancer Res 43: 517–520
Herman TS (1983) Effect of temperature on the cytotoxicity of vindesine, amsacrine, and mitoxantrone. Cancer Treat Rep 67: 1019–1022
Hermann TS, Cress AE, Sweets C, Gerner EW (1981) Reversal of resistance to methotrexate by hyperthermia in Chinese hamster ovary cells. Cancer Res 41: 3840–3843
Herman TS, Sweets CC, White DM, Gerner EW (1982) Effect of rate of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. J Natl Cancer Inst 68: 487–492
Herman TS, Zukoski CF, Anderson RM, Hutter JJ, Blitt CD, Malone JM, Larson DF, Dean FC, Roth HB (1982) Whole-body hyperthermia and chemotherapy for treatment of patients. Cancer Treatm Rep 66: 259–265
Hinkelbein W, Menger D, Birmelin M, Engelhardt R (1984) The influence of whole-body hyperthermia on myelotoxicity of doxorubicin and irradiation in rats. In: Proceedings of the 4th international symposium on hyperthermie oncology, vol 1, Aarhus, Denmark, 2–6 July 1984, pp 281–283
Hiramoto R, Ghanta VK, Lilly MB (1984) Reduction of tumor burden in a murine osteosarcoma following hyperthermia combined with cyclophosphamide. Cancer Res 44: 1405–1408
Honess DJ (1983) Animal models in the evaluation of therapeutic gain of thermochemotherapy. In: Spitzy KH et al (eds) Proc of the 13th int congress of chemotherapy, Vienna, August 28-September 2,1983. pp 273/15–273/18
Honess DJ, Bleehen NM (1982) Sensitivity of normal mouse marrow and RIF-1 tumor to hÿperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain. Br J Cancer 46: 236–248
Honess DJ, Bleehen NM (1985) Potentiation of melphalan by systemic hyperthermia in mice: therapeutic gain for mouse lung microtumours. Int J Hyperthermia 1: 57–68
Honess DJ, Donaldson J, Workman P, Bleehen NM (1985) The effect of systematic hyperthermia on melphalan pharmacokinetics in mice. Br J Cancer 51: 77–84
Janoff KA, Moseson D, Nohigren J, Davenport C, Richards C, Fletcher WS (1982) The treatment of stage I melanoma of the extremities with regional hyperthermia isolation perfusion. Ann Surg 196: 316–323
Ishida A, Mizuno S (1981) Synergistic enhancement of bleomycin cytotoxicity toward tumor cells in culture by a combination of ethanol and moderate hyperthermia. Gann 72: 455–458
Ishida A, Mizuno S (1982) Effects of hyperthermia and ethanol on the cytotoxicity of bleomycin, adriamycin, cis-diamminedichloroplatinum (II) and macromomycin toward Hela cells. Gann 73: 129–131
Issels RD, Biaglow JE, Epstein L, Gerweck LE (1984) Enhancement of cysteamine cytotoxicity by hyperthermia and its modification by catalase and superoxide dismutase in Chinese hamster ovary cells. Cancer Res 44: 3911–3915
Johnson HA, Pavelec M (1973) Thermal enhancement of thio-TEPA cytotoxicity. J Natl Cancer Inst 50: 903–908
Joiner MC, Steel GG, Stephens TC (1982) Response of two mouse tumors to hyperthermia with CCNU or Melphalan. Br J Cancer 45: 17–27
Joshi DS, Barendsen GW (1984) Hyperthermic modification of drug effectiveness for reproductive death of cultured mammalian cells. Indian J Exp Bio122: 251–254
Kamura T, Aoki K, Nishikawa K, Baba T (1979) Antitumor effect of thermodifferential chemotherapy with carboquone on Ehrlich carcinoma. Gann 70: 783–790
Kano E, Furukawa M, Yoshikawa S, Tsubouchi S, Kondo T, SugaharaT (1984) Hyperthermic chemopotentiation and chemical thermosensitisation. Hyperthermic oncology 1984, vol 1, summary papers. Proceedings of the 4th int symp on hyperthermic oncology, Aarhus, Denmark, 2–6 July 1984, pp 437–440
Kato N, Hosoi M, Ohta K, Yamanaka N, Morita K, Ota K (1982) Clinical study of extracorporeal total body hyperthermia. IVth meeting of the European Co-operative Hyperthermia Group, London, 1–2 July 1982. Strahlentherapie 158: 384
Kidera Y, Baba T (1978) Blood flow-interrupting hyperthermic chemotherapy on established autochtonous mouse sarcoma induced by 3-methycholanthrene. Cancer Res 38: 556–559
Kim YD, Lees DE, Lake CR, Whang-Peng J, Schütte W, Smith R, Bull J (1979) Hyperthermia potentiates doxorubicin-related cardiotoxic effects. JAMA 241:1816–1817
Kim JH, Kim SH, Alfieri AA, Young CW (1984) Quercetin, an inhibitor of lactate transport and a hyperthermic sensitizer of Hela cells. Cancer Res 44: 102–106
Kim JH, Kim SH, Alfieri A, Young CW, Silvestrini B (1984) Lonidamine: a hyperthermic sensitizer of HeLa cells in culture and of the meth-A tumor in vivo. Oncology 41: 30–35
Klein ME, Frayer K, Bachur NR (1977) Hyperthermic enhancement of chemotherapeutic agents in L1210 leukemia. Blood 50 5: 223
Klein ME, Frayer K, Gangji D (1977) Hyperthermic potentiation of daunorubicin in L1210 leukemia. Proceedings Sixty-eighth annual meeting of the American Association of Cancer Research, 18–21 May 1977, Denver, Colorado, AACR Abstracts 209
Koga S, Hamazoe R, Maeta M, Shimizu N, Kanayama H, Osaki Y (1984) Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res 44: 1840–1842
Kostic L, Djordjevic O, Brkic G (1978) Effect of hyperthermia and chemotherapeutic agents on the survival of isolated mammalian cells. In: Streffer C, Van Beuningen D, Dietzel F, Roettinger E, Robinson JE, Scherer E, Seeber S, Trott KR (eds) Cancer therapy by hyperthermia and radiation. Proceedings of the 2nd international symposium, Essen, 2–4 June 1977. Urban and Schwarzenberg, Baltimore, pp 281–282
Krementz ET (1983) Chemotherapy by isolated regional perfusion for melanoma of the limbs. In: Schwemmle K, Aigner K (eds) Vascular perfusion in cancer therapy. Springer, Berlin Heidelberg New York, pp 193–203 (Recent results in cancer research, vol 86)
Kremkau FW, Kaufmann JS, Walker MM, Burch PG, Spun CL (1976) Ultrasonic enhancement of nitrogen mustard cytotoxicity in mouse leukemia. Cancer 37: 1643–1647
Kubota Y, Nishimura R, Takai S, Umeda M (1979) Effect of hyperthermia on DNA single-strand breaks induced by bleomycin in HeLa cells. Gann 70: 681–685
Kubota Y, Shuin T, Miura T, Nishimura R, Fukushima S, Takai S (1984) Treatment of bladder cancer with a combination of hyperthermia, radiation and bleomycin. Cancer 53: 199–202
Lange J, Zänker KS, Siewert JR, Eisler K, Landauer B, Kolb E, Blümel G, Remy W (1983) Extrakorporal induzierte Ganzkörperhyperthermie bei konventionell inkurablen Malignompatienten. Dtsch Med Wschr 108: 504–509
Lange I, Zänker KS, Siewert JR, Blümel G, Eisler K, Kolb E (1984) The effect of whole body hyperthermia on 5-fluorouracil pharmakokinetics in vivo and clonogenicity of mammalian colon cancer cells. Anticancer Res 4: 27–32
Langer M, Weidenmaier W, Röttinger EM (1982) Increased cytotoxicity of misonidazole by pH reduction and 41° C hyperthermia in Chinese hamster cells. Strahlentherapie 158: 688–691
Larkin JM (1979) A clinical investigation of total-body hyperthermia as a cancer therapy. Cancer Res 39: 2252–2254
Latreille J, Barlogie B, Yip E, Reilly E, Freireich EJ (1979) Total body hyperthermia (TBH) with and without chemotherapy (CT) for advanced malignancies. Seventieth annual meeting of the American Association for Cancer Research, 16–19 May 1979, New Orleans, Louisiana. Proc Am Assoc Cancer Res 20: 58
Lehman CM, Stewart JR (1983) In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor. Radiat Res 96: 628–634
Li GC (1984) Thermal biology and physiology in clinical hyperthermia: current status and future needs. Cancer Res (Suppl) 44: 4886s-4893s
Li GC, Hahn GM (1978) Ethanol-induces tolerance to heat and to adriamycin. Nature 274: 699–701
Li DJ, Hahn GM (1984) Responses of RIF tumors to heat and drugs: dependence on tumor size. Cancer Treat Rep 68: 1149–1151
Lin PS, Turi A, Kwock E, Lu RC (1982) Hyperthermic effect on microtubule organization. Natl Cancer Int Monogr 61: 57–60
Lin PS, Cariani PA, Jones M, Kahn PC (1983) Work in progress: the effect of heat on bleomycin cytotoxicity in vitro and on the accumulation of co-bleomycin in heat-treated rat tumors. Radiology 146: 213–217
Lin PS, Hefter K, Jones M (1983) Hyperthermia and bleomycin schedules on V79 Chinese hamster cell cytotoxicity in vitro. Cancer Res 43: 4557–4561
Longo FW, Tomashefsky P, Rivin BD, Tannenbaum M (1983) Interaction of ultrasonic hyperthermia with two alkylating agents in a murine bladder tumor. Cancer Res 43: 3231–3235
Lorenz M, Habs M, Schmähl D (1983) Effect of moderate local hyperthermia combined with chemotherapy by administration of cyclophosphamide or N-nitroso-1,3-bis (2-chloroethyl) urea (BCNU) on Yoshida sarcoma implanted in the descending colon of rats. Langenbecks Arch Chir 359: 205–213
Lorenz M, Biwer E, Habs M, Schmähl D (1984) Wirkung der lokalen moderaten Hyperthermie in Kombination mit einer Chemotherapie durch N-nitrose-1,3-bis-(2-chloroethyl)-harnstoff (BCNU) auf das in das Colon descendens der Ratte transplantierte Yoshida-Sarkom. 2. Mitteiluhg: Monochemotherapie in Kombination mit nachfolgender Hyperthermie in unterschiedlichen Zeitintervallen. Langenbecks Arch Chir 362: 253–261
Ludlum DB (1977) Alkylating agents and nitrosoureas. In: Becker SF (ed) Cancer: a comprehensive treatise, vol 5. Plenum, New York, pp 285–307
Maata M, Koga S, Shimizu N, Kanayama H, Hamazoe R, Karino T, Yamane T, Oda M (1984) Effect of extracorporeally induced total body hyperthermia for cancer on cardiovascular function. Jpn Heart J 25: 993–1000
Magin RL (1983) Hyperthermia and chemotherapy: when will they be used in clinical treatment of cancer? Eur J Cancer Clin Oncol 19: 1655–1658
Magin RL, Niesman MR (1984) Temperature-dependent permeability of large unilamellar liposomes. Chem Phys Lipids 34: 245–256
Magin RL, WeinsteinJN (1982) Delivery of drugs in temperature-sensitive liposomes. In: Gregoriadis, Senior, Trouet (eds) Targeting of drugs. Plenum, New York, pp 203–221
Magin RL, Sikic BI, Cysyk RL (1979) Enhancement of bleomycin activity against Lewis lung tumors in mice by local hyperthermia. Cancer Res 39: 3792–3795
Magin RL, Cysyk RL, Litterst CL (1980) Distribution of adriamycin in mice under conditions of local hyperthermia which improve systemic drug therapy. Cancer Treat Rep 64: 203–210
Mahaley MS Jr, Woodhall B (1961) Effect of temperature upon the in vitro action of anticancer agents on VX2 carcinoma. J Neurosurg 269–272
Maier-Lenz H, Weth R, Engelhardt R (1983) Pharmakokinetics of cytostatic drugs in men under normothermic and hyperthermic conditions with special reference to antracyclines. In: Engelhardt R, Wallach DH (eds) Proceedings of the 13th international congress of chemotherapy, Vienna. Session 12.10., part 273, Vienna 28 August-2 Sept 1983, pp 23–26
Malangoni MA, Grosfeld JL, Cakmak O, Ballantine TVN (1978) The effect of hyperthermia on survival in transplanted lymphosarcoma. J Pediat Surg 13: 740–745
Mann BD, Storm FK, Morton DL (1983) Predictability of response to clinical thermochemotherapy by the clonogenic assay. Cancer 52: 1389–1394
Marmor JB (1979) Interactions of hyperthermia and chemotherapy in animals. Cancer Res 39: 2269–2276
Marmor JB, Kozak D, Hahn GM (1979) Effects of systematically administered bleomycin or adriamycin with local hyperthermia on primary tumor and lung metastases. Cancer Treat Rep 63: 1311–1325
Massicotte-Nolan P, Glofcneski DJ, Kruuv J, Lepock JR (1981) Relationship between hyperthermic cell killing and protein denaturation by alcohols. Radiat Res 87: 284
Melia O (1985) Combined hyperthermia and cis-diamminedichloroplatinum in BD IX rats with transplanted BT4Atumors. Int J Hyperthermia 1: 171–183
Metelmann HR, von Hoff DD (1979) In vitro activation of dacarbazine (DTIC) for a human clonic system. Int J Cell Cloning 1: 24–32
Meyn RE, Cony PM, Fletcher SE, Demetriades M (1980) Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum (II). Cancer Res 40: 1136–1139
Meyskens FL Jr (1980) Human melanoma colony formation in soft agar. In: Salmon SE (ed) Cloning of human tumor stem cells. Liss, New York, pp 85–99
Mikkelsen RB, Wallach DFH (1982) Transmembrane ion gradients and thermochemotherapy. In: Gautherie M, Albert (eds) Biomedical thermology. International symposium, Straßburg 1982. Liss, New York, pp 103–107
Mikkelsen RB, Lin PS, Wallach DF (1977) Interaction of adriamycin with human red blood cells: a biochemical and morphological study. J Mol Med 2: 33–40
Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207–214
Mimnaugh EG, Waring RW, Sikic BI, Magin RL, Drew R, Litterst CL, Gram TE, Guarino AM (1978) Effect of whole-body hyperthermia on the disposition and metabolism of adriamycin in rabbits. Cancer Res 38: 1420–1425
Miyazaki M, Makowka L, Falk RE, Falk W, Venturi D, Ambus U, Fa1k JA (1983) Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver. Cancer 51:1254–1260
Mizuno S, Ishida A (1981) Potentiation of bleomycin cytotoxicity toward cultured mouse cells by hyperthermia and ethanol. Gann 72: 395–402
Mizuno S, Ishida A (1982) Selective enhancement of the cytotoxicity of the bleomycin derivate, peplomycin by local anesthetics alone and combined with hyperthermia. Cancer Res 42: 4726–4729
Mizuno S, Amagai M, Ishida A (1980) Synergistic cell killing by antitumor agents and hyperthermia in cultured cells. Gann 71: 471–478
Mizuno S, Ishida A, Amagai M (1981) Potentiation of the action of antitumor agents by hyperthermia. Gan Kagakuryoho 8 (Suppl): 147–153
Moffat FL, Rotstein LE, Calhoun K, Langer JC, Makowka L, Ambus U, Palmer JA, Campbell A, Howard V, Mikkelsaar R, Venturi D, Laing D, Fa1k JA, Falk RE (1984) Palliation of advanced head and neck cancer with radiofrequency hyperthermia and cytotoxic chemotherapy. Can J Surg 27: 38–41
Morgan JE, Bleehen NM (1981) Response of EMT6 multicellular tumor spheroids to hyperthermia. Br J Cancer 43: 384–391
Morgan JE, Bleehen NM (1981) Interactions between misonidazole and hyperthermia in EMT6 spheroids. Br J Cancer 44: 810–818
Morgan J, Honess D, Bleehen N (1979) The interaction of thermal tolerance with drug cytotoxicity in vitro. Br J Cancer 39: 422–428
Muckle DS, Dickson JA (1983) Hyperthermia (42° C) as an adjuvant to radiotherapy and chemotherapy in the treatment of the allogeneic VX2 carcinoma in the rabbit. Br J Cancer 27: 307–315
Murphree SA, Cunningham LS, Hwang KM et al (1976) Effects of adriamycin on surface properties of sarcoma 180 ascites cells. Biochem Pharmaco 125: 1227–1231
Murray D, Milas L, Meyn RE (1984) DNA damage produced by combined hyperglycemia and hyperthermia in two mouse fibrosarcoma tumors in vivo. Int J Radiat Oncol Biol Phys 10: 1679–1682
Murthy MS, Khandekar JD, Travis JD, Scanlon EF (1984) Combined effect of hyperthermia (HT) and platinum compounds in vivo and in vitro on murine and human tumor cells. Hyperthermic oncology 1984, vol 1. Proc of the 4th int symp on hyperthermic oncology, Aarhus, Denmark (2–6 July 1984), pp 421–424
Nakajima K, Hisazumi H (1983) An experimental study of enhanced cell killing by hyperthermia and bleomycin. Urol Res 11: 43–46
Nauts HC (1985) Hyperthermic oncology: historic aspects and future trends. In: Overgaard J (ed) Hyperthermic oncology 1984, vol 2. Proceedings of the 4th int symp on hyperthermic oncology, Aarhus, Denmark (2–6 July 1984). Taylor and Francis, London, pp 199–209
Neumann H, Engelhardt R, Fabricius HA, Stahn R, Loehr GW (1979) Klinisch-chemische Untersuchungen an Tumorpatienten unter Zytostatica-and Ganzkörperhyperthermiebehandlung. Klin Wschr 57: 1311–1315
Neumann HA, Fiebig HH, Löhr GW, Engelhardt R (1985) Effects of cytostatic drugs and 40.5° C hyperthermia on human clonogenic tumor cells. Eur J Cancer Clin Oncol 21: 515–523
Neumann HA, Fiebig HH, Löhr GW, Engelhardt R (1985) Effects of cytostatic drugs and 40.5° C hyperthermia on human bone marrow progenitors (CFU-C) and human clonogenic tumor cells implanted into mice. JNCI 75:1059–1066
Neville AJ, Robins HI, Martin P, Gilchrist KW, Dennis WH, Steeves RA (1984) Effect of whole body hyperthermia and BCNU on the development of radiation myelitis in the rat. Int J Radiat Biol 46: 417–420
O’Donnell JF, Mockoy WS, Makuch RW, Bull JM (1979) Increased in vitro toxicity to mouse bone marrow with 1,3-bis(2-chloroethyl)-1-nitrosourea and hyperthermia. Cancer Res 39: 2547–2549
Ohnoshi T, Ohnuma T, Beranek JT, Holland JF (1985) Combined cytotoxicity effect of hyperthermia and anthracycline antibiotics on human tumor cells. JCNI 71: 275–281
Orth PE, Swidler HJ, Zarakov MS (1977) Survival of pleomorphic sarcoma-37 transplanted virgin female DBA/2J mice: hyperthermia and hyperglycemia, alone and in combination with drugs. J Pharmaceut Sci 66: 437–438
Osieka R, Magin RL, Atkinson ER (1978) The effect of hyperthermia on human colon cancer xemografts in nude mice. In: Streffer C, Van Beuningen D, Dietzel F, Roettinger E, Robinson JE, Scherer E, Seeber S, Trott KR (eds) Cancer therapy by hyperthermia and radiation. Proceedings of the 2nd international symposium, Essen, 2–4 June 1977. Urban and Schwarzenberg, Baltimore, pp 287–290
Ostrow S, Van Echo D, Egorin M, Whitacre M, Grochow L, Aisner J, Colvin M, Bachur M, Bachur N, Wiernik PH (1982) Cyclophosphamide pharmacokinetics in patients receiving whole-body hyperthermia. In: Dethlefsen LA, Dewey WC (eds) 3rd international symposium: cancer therapy by hyperthermia, drugs and radiation, Ft Collins, Colorado 1980. Natl Cancer Inst Monogr 61: 401–403
Overgaard J (1976) Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo. Cancer Res 36: 3077–3081
Palzer RJ, Heidelberger C (1973) Influence of drugs and synchrony on the hyperthermic killing of HeLa cells. Cancer Res 33: 422–427
Parks LC, Smith GV (1980) Extracorporeal induction of systemic hyperthermia techniques; effects on man and malignancy. Department of Surgery, University of Mississippi Medical Center, Jackson, Mississippi
Parks LC, Minaberry D, Smith DP, Neely WA (1979) Treatment of far-advanced bronchogenic carcinoma by extracorporeally induced systemic hyperthermia. 59th Annual Meeting of the American Association for Thoracic Surgery, Boston, Mass, April 30 to May 2, 1979. J Thorax Cardiovasc Surg 78: 883–892
Pettigrew RT, Ludgate CW (1977) Whole-body hyperthermia. A systemic treatment for disseminated cancer. In: Rossi-Fanelli A, Cavaliere R, Mondovi B, Moricca G (eds) Selective heat sensitivity of cancer cells. Springer, Berlin Heidelberg New York, pp 153–170
Pettigrew RT, Ludgate CM, Gee AP, Smith AN (1978) Whole-body hyperthermia combined with chemotherapy in the treatment of advanced human cancer. In: Streffer C, Van Beuningen D, Dietzel F, Roettinger E, Robinson JE, Scherer E, Seeber S, Trott KR (eds) Cancer therapy by hyperthermia and radiation. Proceedings of the 2nd international symposium, Essen 1977. Urban and Schwarzenberg, Baltimore, pp 337–339
Pigram WJ, Fuller W, Amilton LDH (1972) Stereochemistry of intercalation: interaction of daunomycin with DNA. Nature (New Biol) 235: 17–19
Pomp H (1978) Clinical application of hyperthermia in gynecological malignant tumors. In: Streffer C, Van Beuningen D, Dietzel F, Roettinger E, Robinson JE, Scherer E, Seeber S, Trott KR (eds) Cancer therapy by hyperthermia and radiation. Proceedings of the 2nd international symposium, Essen, 2–4 June 1977. Urban and Schwarzenberg, Baltimore, pp 326–327
Raaphorst GP, Azzam EI, Einspenner M, Vadasz JA (1984) Inhibition of DMSO-induced differentiation by hyperthermia in a murine erythroleukemia cell system. Can J Biochem Cell Biol 62: 1091–1096
Rabbani B, Sondhaus CA, Swingle KF (1978) Cellular response to hyperthermia and bleomycin: effect of time sequencing and possible mechanisms. In: Streffer C, Van Beuningen D, Dietzel F, Roettinger E, Robinson JE, Scherer E, Seeber S, Trott KR (eds) Cancer therapy by hyperthermia and radiation. Proceedings of the 2nd international symposium, Essen, 2–4 June 1977. Urban and Schwarzenberg, Baltimore, pp 291–293
Rege YB, Leone LA, Soderberg CH, Coleman GV, Robidoux HJ, Fijman R, Brown J (1983) Hyper-thermic adjuvant perfusion chemotherapy for stage I malignant melanoma of the extremity with literature review. Cancer 52: 2033–2039
Robins HI (1984) Role of whole body hyperthermia in the treatment of neoplastic disease: its current status and future prospects. Cancer Res (Suppl) 44: 4878s-4883s
Robins HI, Dennis WH, Slattery IS, Lange TA, Yatvin MB (1983) Systemic lidocaine enhancement of hyperthermia-induced tumor regression in transplantable murine tumor models. Cancer Res 43: 3187–3191
Robins HI, Grossman J, Davis TE, Aubuchon JP, Dennis W (1983) Preclinical trial of a radiant heat device for whole-body hyperthermia using a porcine model. Cancer Res 43: 2018–2022
Robins HI, Dennis WH, Martin PA, Sondel PM, Yatvin MB, Steeves RA (1984) Potentiation of differential hyperthermie sensitivity of AKR leukemia and normal bone marrow cells by lidocaine or thiopental. Cancer 54: 2831–2835
Rochlin DB, Thaxter TH, Dickerson AG, Shiner J (1961) The effect of tissue temperature on the binding of alkylating agents in the isolation perfusion treatment of cancer. Surg Gyn Obstet 113: 555–561
Roizin-Towle L, Hall EJ (1982) Interaction hyperthermia and cytotoxic agents. In: Dethlefsen LA, Dewey WC (eds) 3rd international symposium: cancer therapy by hyperthermia, drugs and radiation, Ft Collins, Colorado 1980. Natl Cancer Inst Monogr 61:149–151
Rose WC, Veras GH, Laster WR Jr, Schabel FM Jr (1979) Evaluation of whole-body hyperthermia as an adjunct to chemotherapy in murine tumors. Cancer Treat Rep 63:1311–1325
Rotstein LE, Daly J, Rozsa P (1983) Systemic thermochemotherapy in a rat model. Can J Surg 26: 113–116
Senapati N, Houchens D, Ovejera A, Beard R, Nines R (1982) Ultrasonic hyperthermia and drugs as therapy for human tumor xenografts. Cancer Treatm Rep 66: 1635–1639
Shingelton WW, Parker RT, Mahaley S (1961) Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia. Surgery 50: 260–265
Shingleton WW, Bryan FA Jr, O’Quinn WL, Krueger LC (1962) Selective heating and cooling of tissues in cancer chemotherapy. Ann Surg 156: 408–416
Silvestrini B, Hahn GM, Cioli V, Demartino C (1983) Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumor systems. Br J Cancer 47: 221–231
Skibba JL, Jones FE, Condon RE (1982) Altered hepatic disposition of doxorubicin in the perfused rat liver at hyperthermic temperatures. Cancer Treat Rep 66: 1357
Sugarbaker EV, McBride CM (1976) Survival and regional disease control after isolation perfusion for invasive stage I melanoma of the extremities. Cancer 37: 188–198
Sutherland CM, Krementz ET (1979) Systemic hyperthermia induced by partial cardio-pulmonary bypass for treatment of metastatic tumors. Fifteenth annual meeting of the American Society of Clinical Oncology, 14–15 May 1979, New Orleans. Proc Am Soc Clin Onco 120: 374
Suzuki K (1967) Application of heat to cancer chemotherapy: experimental studies. Nagoya J Med 30: 1–21
Szczepanski L, Trott KR (1981) The combined effect of bleomycin and hyperthermia on the adenocarcinoma 284 of the C3H mouse. Eur J Cancer Clin Onco 117: 997–1000
Schraffordt-Koops H, Beekhius H, Oldhoff J, Osterhuis JW, Van der Ploog E, Vermey A (1981) Local recurrence and survival in patients with (Clark Level IV/V and over 1.5 mm thickness) stage I malignant melanoma of the extremities after regional perfusion. Cancer 48:1952–1957
Schrak R, Stefani SS (1981) Effects of alcohol and hyperthermia on normal and leukemic lymphocytes. Oncology 38: 69–71
Stehlin JS Jr (1969) Hyperthermic perfusion with chemotherapy for cancers of the extremities. Surg Gynecol Obstet 120: 305–308
Stehlin JS Jr, Giovanella BC, Ipolyi de PD, Muenz LR, Anderson RF (1975) Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynec Obstet 140: 339–348
Stehlin JS Jr, Giovanella BC, Gutierrez AE, Ipolyi de PD, Greff PJ (1984) 15 year’s experience with hyperthermic perfusion for treatment of soft tissue sarcoma and malignant melanoma of the extremities. In: Veath JM (ed) Hyperthermia and radiation therapy/chemotherapy in the treatment of cancer. Frontiers of radiation therapy and oncology, vol 18. Karger, Basel, pp 177–182
Storm FK, Kaiser LR, Goodnight JE, Harrison WH, Elliott RS, Gomes AS, Morton DL (1982) Thermochemotherapy for melanoma metastases in liver. Cancer 49: 1243–1248
Storm KF, Baker HW, Scanlon EF, Plenk HP, Meadows PM, Cohen SC, Olson CE, Thomson JW, Khandekar JD, Rose D, Nizze A, Morton DL (1985) Magnetic-induced hyperthermia. Results of a 5-year multi-institutional national cooperative trial in advanced cancer patients. Cancer 55: 2677–2687
Tacker JR, Anderson RU (1982) Delivery of antitumor drugs to bladder cancer by use of phase transition liposomes and hyperthermia. J Uro 1127: 1211–1214
Takeshita M, Grollmann AP, Ohtsubo E et al (1978) Interaction of bleomycin with DNA. Proc Natl Acad Sci USA 75: 5983–5987
Takiyama W (1984) Experimental studies on combined chemotherapy with hyperthermia and ethanol for advanced esophageal cancer. II. Effects of combined treatments on tumor growth in tumor-bearing mice. Nippon Geka Gakki Zasshi 85: 118 (Abstract)
Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC (1981) Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 41: 1096–1099
Thuning CA, Bakir NA, Warren J (1980) Synergistic effect of combined hyperthermia and a nitrosourea in treatment of a murine ependymoblastoma. Cancer Res 40: 2726–2729
Tonak J, Hohenberger W, Weidner F, Göhl H (1983) Hyperthermic perfusion in malignant melanoma: 5-years result. Springer, Berlin Heidelberg New York, pp 229–233 (Recent results in cancer research, vol 86)
Twentyman PR, Morgan JE, Donaldson J (1978) Enhancement by hyperthermia of the effect of BCNU against the EMT6 mouse tumor. Cancer Treat Rep 62: 439–443
Umezawa H, Hori S, Sawa T et al (1974) A bleomycin-inactivating enzyme in mouse liver. J Antibiotics 27: 419–424
Urano M, Kim MS (1983) Effect of hyperglycemia in thermochemotherapy of a spontaneous murine fibrosarcoma. Cancer Res 43: 3041–3044
Urano M, Overgaard M, Suit H, Dunn P, Sedlacek R (1978) Enhancement by Corynebacterium parvum of the normal and tumor tissue response to hyperthermia. Cancer Res 38: 862–864
Urano M, Suit HD, Dunn P, Landsdale T, Sedlacek RS (1979) Enhancement of the thermal response of animal tumors by Corynebacterium parvum. Cancer Res 39: 3454–3457
Urano M, Yamashita T, Suit HD, Gerweck LE (1984) Enhancement of thermal response of normal and malignant tissues by Corynebacterium parvum. Cancer Res 44: 2341–2347
Van der Linden PWG, Sapareto SA, Corbett TH, Valeriote FA (1984) Adriamycin and heat treatments in vitro and in vivo. Hyperthermic oncology 1984, vol 1, summary papers. Proceedings of the 4th international symp on hyperthermic oncology, Aarhus, Denmark, 2–6 July 1984, pp 449–452
Vanderzee J, Vanrhoon GC, Wikehooley JL, Faithfull NS, Reinhold HS (1983) Whole body hyperthermia in cancer therapy - a report of a phase I-II study. Eur J Cancer Clin Onco 119:1189–1200
Vig BK, Cornforth M, Farook SAF (1982) Hyperthermic potentiation of chromosome aberrations by anticancer antibiotics. Cytogenet Cell Genet 33: 35–41
Wallach DFH (1977) Basic mechanisms in tumor thermotherapy. J Mol Med 2: 381–403
Wallach DFH, Madoc-Jones H, Sternick ES, Santoro JJ, Curran B (1982) Moderate-temperature whole-body hyperthermia in the treatment of malignant disease. In: Gautherie M, Albert E (eds) Biomedical thermology. International symposium, Straßburg 1981. Liss, New York, pp 715–720
Waring MJ (1976) DNA-binding characteristics of acridinil-methanesulphonanilide drugs: comparison with antitumor properties. Eur J Cancer 12: 995–1001
Weinstein JN, Magin RL, Cysyk RL, Zaharko DS (1980) Treatment of solid L 1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate. Cancer Res 40: 1388–1395
West KW, Weber TR, Grosfeld JL (1980) Synergistic effect of hyperthermia, papaverine, and chemotherapy in murine neuroblastoma. J Pediat Surg 15: 913–917
Westphal O, Westphal U, Sommer T (1977) The history of pyrogen research. American Society for Microbiology, pp 221–238
Wike-Hooley JL, Haveman J, Reinhold HS (1984) The review of tumour pH to the treatment of malignant disease. Radiotherapy and Oncology 2: 343–366
Wike-Hooley JL, van der Zee J, van Rhoon GC, van den Berg AP, Reinhold HS (1984) Human tumor pH changes following hyperthermia and radiation therapy. Eur J Cancer Clin Oncol 20: 619–623
Wile AG, Nahabedian MY, Plumley DA, Guilmette JE, Mason GR (1983) Experimental hyperthermic isolation-perfusion using cis-diamminedichloroplatinum (II). Cancer Res 43: 3108–3111
Willnow U (1981) The effect of hyperthermia alone or in combination with actinomycin D on the RNA metabolism of solid tumors in children. Neoplasma 28: 721–729
Wüst GP, Norpoth K, Witting U, Oberwittler W (1973) Der in vitro-Effekt der Hyperthermie auf Ein- bau von Nucleinsäurevorläufern in Tumoren and normale Gewebe. Z Krebsforsch 79:193–203
Yamada K, Someya F, Shimada S, Ohara K, Kukíta A (1984) Thermochemotherapy for malignant melanoma: combination therapy of ACNU and hyperthermia in mice. J Invest Dermatol 82: 180–184
Yamanaka N, Kato N, Hosoi M, Kazuhiro Ota, Morita K, Kazuo O (1982) Total body hyperthermia re-sensitizes doxorubicin against human neo-plasma resistant to doxorubicin. The Bio-Dynamics Res Inst and Shinseikai Hospital, Japan IVth Meeting of the European Co-operative Hyperthermia Group, London, 1–2 July 1982. Strahlentherapie 158: 392
Yamane T, Koga S, Maeta M, Hamazoe R, Karino T, Oda M (1984) Effects of in vitro hyperthermia on concentration of adriamycin in Ehrlich ascites cells. Hyperthermic oncology 1984, vol 1, summary papers. Proceedings of the 4th international symp on hyperthermic oncology, Aarhus, Denmark, 2–6 July 1984, pp 409–412
Yang SJ, Rafla S (1985) Temperature effect on mitoxantrone cytotoxicity in Chinese hamster cells in vitro. Cancer Res 45: 3593–3597
Yatvin M (1977) The influence of membrane lipid composition and procaine on hyperthermic death of mice cells. Int J Radiat Biol 32: 513–523
Yatvin MB, Clifton KH, Dennis WH (1979) Hyperthermia and local anesthetics: potentiation of survival of tumor-bearing mice. Science 205:195–196
Yatvin MB, Mühlensiepen H, Porschen W, Weinstein JN, Feinendegen LE (1981) Selective delivery of liposome-associated cis-dichlorodiammineplatinum (II) by heat and its influence on tumor drug uptake and growth. Cancer Res 41: 1602–1607
Yerushalmi A (1978) Combined treatment of a solid tumour by local hyperthermia and actinomycinD. Br J Cancer 37: 827–832
Yerushalmi A (1978) Simulation of resistance against local tumour growth of hosts: pretreated by combined local hyperthermia and x-irradiation. Bull Cancer 65: 475–478
Yerushalmi A, Hazan G (1979) Control of Lewis lung carcinoma by combined treatment with local hyperthermia and cyclophosphamide: preliminary results. Isr J Med Sci 15: 462–463
Yerushalmi A, Tovey MG, Gresser I (1982) Antitumor effect of combined interferon and hyperthermia in mice. Proc Soc Exp Biol Med 169: 413
Zupi G, Badaracco G, Cavaliere R, Natali PG, Greco C (1984) Influence of sequence on hyperthermia and drug combination. Hyperthermic oncology 1984, vol 1. Proc of the 4th int symp on hyper-thermic oncology, Aarhus, Denmark, 2–6 July 1984, pp 429–432
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Engelhardt, R. (1987). Hyperthermia and Drugs. In: Streffer, C. (eds) Hyperthermia and the Therapy of Malignant Tumors. Recent Results in Cancer Research, vol 104. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82955-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-82955-0_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82957-4
Online ISBN: 978-3-642-82955-0
eBook Packages: Springer Book Archive